D-psicose 3-epimerase mutant with improved thermal stability, and continuous production of D-psicose using same
US-9217166-B2 · Dec 22, 2015 · US
US11046986B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11046986-B2 |
| Application number | US-201916582385-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2019 |
| Priority date | Mar 28, 2017 |
| Publication date | Jun 29, 2021 |
| Grant date | Jun 29, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for producing RNA is provided. Objective RNA is produced by culturing a coryneform bacterium having an expression unit for the objective RNA, which has been modified so that the activity of ribonuclease III is reduced, in a medium, to express the objective RNA and accumulate the objective RNA in cells of the bacterium, and collecting the objective RNA from the cells.
Opening claim text (preview).
We claim: 1. A method for producing objective RNA, the method comprising: A) culturing a coryneform bacterium having an expression unit for the objective RNA in a medium, to express the objective RNA and accumulate the objective RNA in cells of the bacterium; and B) collecting the objective RNA from the cells, wherein the bacterium has been modified so that the activity of ribonuclease III is reduced as compared with a non-modified strain by deletion of a gene encoding ribonuclease III; wherein the ribonuclease III is a protein selected from the group consisting of: (a) a protein comprising the amino acid sequence of SEQ ID NO: 52; (b) a protein comprising the amino acid sequence of SEQ ID NO: 52, but which includes substitution, deletion, insertion, and/or addition of 1 to 10 amino acid residues, and having ribonuclease III activity; and (c) a protein comprising an amino acid sequence having an identity of 90% or higher to the amino acid sequence of SEQ ID NO: 52, and having ribonuclease III activity. 2. The method according to claim 1 , wherein the bacterium comprises 5 copies/cell or more of the expression unit. 3. The method according to claim 1 , wherein the bacterium comprises 70 copies/cell or more of the expression unit. 4. The method according to claim 1 , wherein the bacterium comprises a vector containing the expression unit. 5. The method according to claim 1 , wherein the expression unit comprises a promoter sequence that functions in the coryneform bacterium and a nucleotide sequence encoding the objective RNA in the direction from 5′ to 3′. 6. The method according to claim 5 , wherein the promoter sequence is a promoter derived from a phage. 7. The method according to claim 5 , wherein the promoter sequence is F1 promoter or T7 promoter. 8. The method according to claim 5 , wherein the promoter sequence is a promoter selected from the group consisting of: (a) a promoter comprising the nucleotide sequence of SEQ ID NO: 13 or 78; and (b) a promoter comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of SEQ ID NO: 13 or 78. 9. The method according to claim 1 , wherein the bacterium is a bacterium belonging to the genus Corynebacterium. 10. The method according to claim 1 , wherein the bacterium is Corynebacterium glutamicum.
Related publications grouped by family.
Answers are generated from the same data shown on this page.